This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2017-2022.
Company Filing History:
Years Active: 2017-2022
Title: The Innovative Contributions of Sabine Raab
Introduction
Sabine Raab is a prominent inventor based in Rosbach, Germany. She has made significant contributions to the field of medical research, particularly in the development of antibodies for the treatment of various diseases. With a total of 2 patents to her name, her work has the potential to impact the lives of many patients suffering from serious health conditions.
Latest Patents
One of her latest patents is focused on an anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders. This invention relates to the prophylaxis and treatment of fibrosis through the administration of antibodies, specifically targeting patients suffering from systemic sclerosis and other fibrotic diseases affecting the skin, lung, heart, liver, and kidney. Another significant patent addresses the treatment of prostate cancer using an anti-alpha-v integrin antibody. This invention is particularly aimed at patients with castration-resistant prostate cancer, including those with lymph node and bone tissue metastases.
Career Highlights
Sabine Raab is currently associated with Merck Patent GmbH, where she continues to advance her research and innovations. Her work is characterized by a strong focus on therapeutic antibodies, which are crucial in the fight against various cancers and fibrotic diseases.
Collaborations
Throughout her career, Sabine has collaborated with notable colleagues, including Andrew Bender and Frederic Christian Pipp. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in medical research.
Conclusion
Sabine Raab's contributions to the field of medical research through her patents and collaborations highlight her role as a leading inventor. Her work not only showcases her innovative spirit but also holds promise for improving treatment options for patients with serious health conditions.